45 employees
Zevra Therapeutics is a biopharmaceutical company focused on discovering and developing therapies for pain, ADHD, and other CNS diseases.
2006
$3.5M
from 2 investors over 2 rounds
Zevra Therapeutics raised $3.5M on August 27, 2009
Investors: BP Growth Partners
Zevra Therapeutics raised $647K on July 14, 2008